These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 1523980)
1. [Clinical study of prophylactic therapy of interferon on postoperative renal cell carcinoma]. Yasumoto R; Asakawa M; Hayahara N; Maekawa T; Wada S; Kishimoto T; Maekawa M; Morikawa Y; Kawakita J; Umeda M Hinyokika Kiyo; 1992 Mar; 38(3):267-75. PubMed ID: 1523980 [TBL] [Abstract][Full Text] [Related]
2. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy. Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma. Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539 [TBL] [Abstract][Full Text] [Related]
4. [Adjuvant interferon alpha in renal carcinoma with a high risk of recurrence. Multicenter pilot study]. Pizzocaro G; Piva L; Faustini M; Nicolai N; Salvioni R; Pisani E; Maggioni A; Mandressi A; Dormia E; Minervini S Arch Ital Urol Androl; 1993 Apr; 65(2):173-6. PubMed ID: 8330063 [TBL] [Abstract][Full Text] [Related]
5. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. Messing EM; Manola J; Wilding G; Propert K; Fleischmann J; Crawford ED; Pontes JE; Hahn R; Trump D; J Clin Oncol; 2003 Apr; 21(7):1214-22. PubMed ID: 12663707 [TBL] [Abstract][Full Text] [Related]
6. [Survival analysis of interferon-alpha on locally advanced clear cell renal cell carcinoma after radical nephrectomy]. Xia J; Li X; Chen XQ; Li X; Zeng H; Wei Q; Zhang P; Zhu YC Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):91-4. PubMed ID: 22455140 [TBL] [Abstract][Full Text] [Related]
7. Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma. Kriegmair M; Oberneder R; Hofstetter A Urology; 1995 May; 45(5):758-62. PubMed ID: 7747370 [TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine. Kinouchi T; Meguro N; Maeda O; Saiki S; Kuroda M; Usami M; Kotake T Int J Urol; 1996 Jan; 3(1 Suppl):S41-3. PubMed ID: 24304021 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma. Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106 [TBL] [Abstract][Full Text] [Related]
10. [Presentation of a randomized multicenter study protocol. "Evaluation of adjuvant interferon effectiveness after radical nephrectomy in kidney carcinoma with high risk of relapse"]. Arch Ital Urol Nefrol Androl; 1990 Mar; 62(1):177-83. PubMed ID: 2141713 [No Abstract] [Full Text] [Related]
11. [Intralesional and transarterial administration of interferon for renal cell carcinoma]. Kitagawa R; Fujime M; Sakamoto Y; Hanazawa K; Fujita K; Isobe H Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1462-5. PubMed ID: 1530294 [TBL] [Abstract][Full Text] [Related]